COMMUNIQUÉS West-GlobeNewswire

Genmab Announces Data to be Presented at 2018 ASH Annual Meeting

01/11/2018 - 14:16

Media Release Thirty-five total abstracts on Genmab owned and partnered programs scheduled for presentation at ASH Three abstracts related to Genmab owned programs: DuoBody ® -CD3xCD20 & DuoHexaBody™-CD37 [...]

Precipio and PerkinElmer Collaborate to Provide Solutions for Liquid Biopsy Testing Workflows

01/11/2018 - 14:15

Precipio ICE COLD-PCR™ reagents will be sold with PerkinElmer DNA/RNA extraction and isolation products NEW HAVEN, Conn., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: [...]

argenx announces new cusatuzumab (ARGX-110) AML data in abstracts published in connection with 60th American Society of Hematology Annual Meeting and Exposition

01/11/2018 - 14:15

Regulated information – Inside information 92% overall response rate with durability up to 14.4 months in ongoing analysis of Phase 1/2 trial Updated results from Phase 1/2 trial of cusatuzumab in CTCL also published [...]

Bio-Path Holdings to Present Clinical Data at the 60th Annual American Society of Hematology Annual Meeting

01/11/2018 - 14:05

HOUSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]

Unum Therapeutics to Present Preliminary Results from Ongoing Phase 1 Studies ATTCK-20-03 and ATTCK-17-01 at the 2018 ASH Annual Meeting

01/11/2018 - 14:01

CAMBRIDGE, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]

Bellicum Announces Data Presentations on Lead Product Candidate Rivo-cel and Controllable CAR Program at the 60th American Society of Hematology Annual Meeting

01/11/2018 - 14:01

Nine abstracts accepted, including two oral presentations HOUSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for [...]

BeiGene to Present Clinical Data on Tislelizumab and Zanubrutinib at the 60th American Society of Hematology Annual Meeting

01/11/2018 - 14:00

Company to Host Investor Meeting and Webcast on Monday, December 3, at 8 pm PST CAMBRIDGE, Mass. and BEIJING, China, Nov. 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE), a commercial-stage biopharmaceutical [...]

Progressive Care Inc. CEO to Speak at 5th Annual Florida Telehealth Summit in St. Pete Beach, Florida

01/11/2018 - 14:00

MIAMI, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that the company will be attending and speaking at the 5th [...]

Konica Minolta Provides New Insights with AeroRemote® Insights

01/11/2018 - 14:00

WAYNE, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- At RSNA 2018, Konica Minolta Healthcare Americas, Inc. will showcase new advancements of the AeroRemote platform. AeroRemote Insights is a comprehensive performance [...]

Forty Seven Inc. to Present New Preclinical Data on 5F9 at the 60th American Society of Hematology (ASH) Annual Meeting

01/11/2018 - 14:00

-- 5F9 Priming Dose Results in CD47 Pruning, Removing CD47 from Surface of Red Blood Cells to Mitigate Risk of Anemia -- -- 5F9 Demonstrates Synergy in Combination with Azacitidine in Acute Myeloid Leukemia (AML) Models [...]

Kura Oncology Announces Upcoming Presentations at ASH Annual Meeting

01/11/2018 - 14:00

SAN DIEGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that two [...]

Miragen Therapeutics to Present New Cobomarsen Phase 1 Clinical Trial Data at the 2018 American Society of Hematology Annual Meeting

01/11/2018 - 14:00

BOULDER, Colo., Nov. 01, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced [...]

Plus Products: Top-Ranked Edibles in California -- CFN Media

01/11/2018 - 14:00

SEATTLE, Nov. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

ATW Tech Closes the Sale of its Atman Assets for $1.3 Million

01/11/2018 - 14:00

MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (TSX-V: ATW) announces today the closing of the sale of its Psychometric Research and Services of Atman assets (“Atman”), previously announced on September 17, [...]

ATW Tech conclut la vente des actifs d’Atman pour 1,3 million

01/11/2018 - 14:00

MONTRÉAL, 01 nov. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la « Société » ou « ATW Tech ») (TSX-V : ATW) annonce aujourd’hui la clôture de la vente de ses actifs des Services et Recherche Psychométrique d‘Atman (« Atman [...]

GBT Announces Upcoming Data Presentations at 60th American Society of Hematology (ASH) Annual Meeting & Exposition

01/11/2018 - 14:00

Company to Present Three Oral Presentations, Including Results Beyond 12 Weeks from Part A of the HOPE Study Company to Host Investor Webcast on Monday, December 3 SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE [...]

Terra Tech Corp. Makes Strategic Investment in Leading Hydroponics Provider

01/11/2018 - 13:41

IRVINE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX: TRTC), (“Terra Tech” or the “Company”) a vertically integrated cannabis-focused agriculture company, is pleased to announce that it has made a $ [...]

Onconova Therapeutics, Inc. to Provide Corporate Update and Third Quarter 2018 Financial Results

01/11/2018 - 13:30

Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday, November 13, 2018 NEWTOWN, Pa., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) , a Phase 3-stage [...]

Eyenovia Announces Conference Call and Webcast for Third Quarter 2018 Financial Results

01/11/2018 - 13:30

NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print technology to deliver microdosed [...]